# Veracyte

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/veracyte

- Industry: Biotechnology
- Headquarters: South San Francisco, US
- Website: www.veracyte.com
- Total disclosed funding: $68M
- Latest round: Series C (Jun 28, 2013)
- Investors on record: 5

## About

Founded in 2008 and based in California, US, Veracyte, Inc., formerly known as Calderome Inc., operates as a developer of genomic diagnostics for thyroid and non-small cell lung cancer.

## Funding rounds

- Series C, Jun 28, 2013, $13M — Domain Associates, GE Capital, Equity, Kleiner Perkins, Versant Ventures, TPG Biotech
- Series C, Nov 6, 2012, $15M — Domain Associates, Kleiner Perkins, Versant Ventures
- Series B, Jun 10, 2010, $28M — Domain Associates, Kleiner Perkins, Versant Ventures, TPG Biotech
- Series A, Mar 11, 2008, $12M — Kleiner Perkins, Versant Ventures, TPG Biotech

## Investors

- Kleiner Perkins (https://capitalatlas.ai/funds/kleiner-perkins) — Series A, Series B, Series C
- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series A, Series B, Series C
- TPG Biotech (https://capitalatlas.ai/funds/tpg-biotech) — Series A, Series B, Series C
- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series B, Series C
- GE Capital, Equity (https://capitalatlas.ai/funds/ge-capital-equity) — Series C